Conclusion

Conclusion

Globally, postpartum haemorrhage (PPH) is the leading cause of maternal morbidity and mortality. Major obstetric haemorrhage is managed by multidisciplinary approach. In the current treatment of severe PPH, first-line therapy includes transfusion of packed cells and fresh-frozen plasma in addition to uterotonic medical management and surgical interventions. In persistent PPH, tranexamic acid, fibrinogen, and coagulation factors are often administered. Secondary coagulopathy due to PPH or its treatment is often underestimated and therefore remains untreated, potentially causing progression to even more severe PPH. The most postnatal haemorrhage is due to uterine atony and can be temporarily controlled with firm bimanual pressure while waiting for definitive treatment.

Competing Interests None declared Author Details RAJASHREE CHAVAN, MBBS, MD, DA, FRCA; Cambridge University Hospital Foundation Trust, UK. M Y LATOO, FRCA(London) Consultant Anaesthetist, Bedford Hospital, UK. CORRESPONDENCE: DR RAJASHREE CHAVAN, Cambridge University Hospital Foundation Trust, UK. Email: vidula77@doctors.net.uk

⇐ Предыдущая 1 2 34